Related Experiment Video
Updated: Aug 5, 2026

Demonstration of Heterologous Complexes formed by Golgi-Resident Type III Membrane Proteins using Split Luciferase Complementation Assay
Published on: September 10, 2020
UDP-galactopyranose mutase has a novel structure and mechanism
D A Sanders1, A G Staines, S A McMahon
1The Centre for Biomolecular Sciences, The University, St. Andrews, Scotland KY16 9ST, UK.
Abstract:
Uridine diphosphogalactofuranose (UDP-Galf ) is the precursor of the d-galactofuranose (Galf ) residues found in bacterial and parasitic cell walls, including those of many pathogens, such as Mycobacterium tuberculosis and Trypanosoma cruzi. UDP-Galf is made from UDP-galactopyranose (UDP-Galp) by the enzyme UDP-galactopyranose mutase (mutase). The mutase enzyme is essential for the viability of mycobacteria and is not found in humans, making it a viable therapeutic target. The mechanism by which mutase achieves the unprecedented ring contraction of a nonreducing sugar is unclear. We have solved the crystal structure of Escherichia coli mutase to 2.4 A resolution. The novel structure shows that the flavin nucleotide is located in a cleft lined with conserved residues. Site-directed mutagenesis studies indicate that this cleft contains the active site, with the sugar ring of the substrate UDP-galactose adjacent to the exposed isoalloxazine ring of FAD. Assay results establish that the enzyme is active only when flavin is reduced. We conclude that mutase most likely functions by transient reduction of substrate.
Insights
UDP-galactopyranose mutase (mutase) is essential for pathogens like Mycobacterium tuberculosis and is a potential therapeutic target. This study reveals its structure and suggests a mechanism involving transient substrate reduction.
Area of Science:
- Biochemistry
- Structural Biology
- Microbiology
Background:
- Uridine diphosphogalactofuranose (UDP-Galf) is crucial for bacterial and parasitic cell walls, including pathogens like Mycobacterium tuberculosis.
- UDP-galactopyranose mutase (mutase) synthesizes UDP-Galf from UDP-galactopyranose (UDP-Galp).
- Mutase is essential for mycobacterial viability and absent in humans, presenting a therapeutic target.
Purpose of the Study:
- To elucidate the structural basis and catalytic mechanism of UDP-galactopyranose mutase.
- To investigate the role of the flavin cofactor in mutase activity.
- To provide insights for the development of novel anti-infective agents.
Main Methods:
- X-ray crystallography to determine the 3D structure of E. coli mutase at 2.4 A resolution.
- Site-directed mutagenesis to identify active site residues.
- Enzyme activity assays to assess the role of flavin reduction.
Main Results:
- The crystal structure revealed a novel cleft containing conserved residues and the flavin adenine dinucleotide (FAD) cofactor.
- Site-directed mutagenesis confirmed the active site location within this cleft, with substrate proximity to FAD.
- Enzyme activity was dependent on the reduced state of the flavin cofactor.
Conclusions:
- UDP-galactopyranose mutase likely functions via transient reduction of its substrate.
- The structural and mechanistic insights advance our understanding of essential microbial pathways.
- This research supports the development of mutase inhibitors as potential therapeutics against pathogens.
Related Concept Videos
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Protein Folding Quality Check in the RER
Biosynthesis of Polysaccharides
Peptidoglycan Synthesis

